| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 77 | 2022 | 516 | 18.310 |
Why?
|
| Vitamin D Deficiency | 47 | 2022 | 292 | 10.060 |
Why?
|
| Milk, Human | 34 | 2022 | 147 | 9.720 |
Why?
|
| Breast Feeding | 27 | 2022 | 159 | 8.040 |
Why?
|
| Lactation | 24 | 2022 | 110 | 6.640 |
Why?
|
| Dietary Supplements | 38 | 2022 | 332 | 6.350 |
Why?
|
| Pregnancy Complications | 19 | 2022 | 286 | 5.380 |
Why?
|
| Pregnancy | 64 | 2023 | 2334 | 4.250 |
Why?
|
| Infant, Newborn | 73 | 2022 | 2455 | 3.470 |
Why?
|
| Vitamins | 21 | 2022 | 134 | 3.370 |
Why?
|
| Infant, Premature | 19 | 2022 | 284 | 3.280 |
Why?
|
| Infant Nutritional Physiological Phenomena | 17 | 2022 | 72 | 2.760 |
Why?
|
| Mothers | 12 | 2022 | 172 | 2.760 |
Why?
|
| Female | 124 | 2023 | 38074 | 2.170 |
Why?
|
| Infant | 40 | 2022 | 2891 | 2.130 |
Why?
|
| Cholecalciferol | 12 | 2021 | 143 | 2.100 |
Why?
|
| Humans | 156 | 2023 | 68618 | 1.950 |
Why?
|
| Bone Density | 4 | 2022 | 159 | 1.890 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 9 | 2020 | 37 | 1.830 |
Why?
|
| Vitamin D-Binding Protein | 6 | 2020 | 58 | 1.750 |
Why?
|
| Pregnancy Trimesters | 3 | 2021 | 14 | 1.650 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2019 | 91 | 1.400 |
Why?
|
| Microbiota | 2 | 2020 | 80 | 1.290 |
Why?
|
| Pre-Eclampsia | 7 | 2020 | 202 | 1.270 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 219 | 1.250 |
Why?
|
| Body Composition | 7 | 2022 | 119 | 1.230 |
Why?
|
| Premature Birth | 4 | 2019 | 150 | 1.220 |
Why?
|
| Infant Formula | 6 | 2022 | 24 | 1.190 |
Why?
|
| Parathyroid Hormone | 7 | 2023 | 117 | 1.180 |
Why?
|
| Galactogogues | 2 | 2018 | 6 | 1.170 |
Why?
|
| Rickets | 4 | 2019 | 20 | 1.090 |
Why?
|
| Nutrition Policy | 4 | 2019 | 44 | 1.080 |
Why?
|
| Bottle Feeding | 3 | 2020 | 20 | 1.070 |
Why?
|
| Double-Blind Method | 11 | 2022 | 1738 | 1.030 |
Why?
|
| Adult | 43 | 2023 | 21403 | 1.010 |
Why?
|
| Sunlight | 8 | 2020 | 59 | 1.000 |
Why?
|
| Placenta | 6 | 2022 | 101 | 0.980 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2022 | 122 | 0.980 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 146 | 0.960 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 219 | 0.920 |
Why?
|
| Food, Fortified | 2 | 2021 | 38 | 0.920 |
Why?
|
| Saliva | 2 | 2015 | 142 | 0.920 |
Why?
|
| Nutritional Requirements | 8 | 2013 | 57 | 0.910 |
Why?
|
| Postpartum Period | 3 | 2020 | 67 | 0.910 |
Why?
|
| Transforming Growth Factor alpha | 7 | 2002 | 30 | 0.870 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 37 | 0.850 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2020 | 154 | 0.830 |
Why?
|
| Intensive Care, Neonatal | 2 | 2018 | 38 | 0.830 |
Why?
|
| Lactalbumin | 1 | 2021 | 2 | 0.810 |
Why?
|
| Cytotoxins | 1 | 2021 | 23 | 0.800 |
Why?
|
| Oleic Acids | 1 | 2021 | 40 | 0.800 |
Why?
|
| Cytokines | 5 | 2021 | 866 | 0.800 |
Why?
|
| Obesity | 8 | 2021 | 1076 | 0.790 |
Why?
|
| Food Handling | 1 | 2021 | 34 | 0.790 |
Why?
|
| Gestational Age | 12 | 2020 | 389 | 0.790 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2020 | 46 | 0.780 |
Why?
|
| Plant Extracts | 2 | 2022 | 122 | 0.770 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2020 | 24 | 0.750 |
Why?
|
| Diet | 6 | 2021 | 514 | 0.740 |
Why?
|
| Avitaminosis | 1 | 2020 | 3 | 0.710 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2019 | 30 | 0.690 |
Why?
|
| Consultants | 1 | 2019 | 12 | 0.680 |
Why?
|
| Pregnancy Outcome | 3 | 2017 | 157 | 0.670 |
Why?
|
| Postnatal Care | 1 | 2019 | 16 | 0.670 |
Why?
|
| Hypocalcemia | 1 | 2019 | 13 | 0.670 |
Why?
|
| Child | 14 | 2022 | 6405 | 0.670 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.660 |
Why?
|
| Vagina | 1 | 2019 | 88 | 0.640 |
Why?
|
| Biomarkers | 11 | 2020 | 1593 | 0.640 |
Why?
|
| Colostrum | 1 | 2018 | 6 | 0.640 |
Why?
|
| Dental Caries | 2 | 2019 | 40 | 0.640 |
Why?
|
| Nursing Research | 1 | 2018 | 40 | 0.630 |
Why?
|
| Body Mass Index | 9 | 2020 | 867 | 0.610 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2017 | 5 | 0.610 |
Why?
|
| Therapeutics | 1 | 2017 | 7 | 0.610 |
Why?
|
| Ergocalciferols | 3 | 2013 | 40 | 0.610 |
Why?
|
| Femur Neck | 1 | 2017 | 3 | 0.610 |
Why?
|
| Hormones | 1 | 2017 | 42 | 0.600 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.600 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.590 |
Why?
|
| Epithelial Cells | 3 | 2017 | 431 | 0.590 |
Why?
|
| Lactulose | 2 | 2015 | 13 | 0.590 |
Why?
|
| Mannitol | 2 | 2015 | 25 | 0.590 |
Why?
|
| Spine | 1 | 2017 | 46 | 0.590 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 33 | 0.580 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2021 | 626 | 0.570 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 65 | 0.570 |
Why?
|
| Skin Pigmentation | 4 | 2017 | 25 | 0.550 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2016 | 21 | 0.540 |
Why?
|
| Lactation Disorders | 1 | 2016 | 3 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 627 | 0.540 |
Why?
|
| Domperidone | 1 | 2016 | 11 | 0.540 |
Why?
|
| Breast Milk Expression | 1 | 2016 | 4 | 0.540 |
Why?
|
| Maternal Welfare | 2 | 2012 | 17 | 0.530 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1851 | 0.530 |
Why?
|
| Young Adult | 15 | 2023 | 5717 | 0.530 |
Why?
|
| Obstetric Labor, Premature | 1 | 2015 | 76 | 0.510 |
Why?
|
| Milk | 3 | 2008 | 43 | 0.510 |
Why?
|
| Down-Regulation | 1 | 2017 | 447 | 0.510 |
Why?
|
| Male | 41 | 2021 | 37321 | 0.500 |
Why?
|
| Prenatal Care | 3 | 2017 | 117 | 0.490 |
Why?
|
| Streptococcus mutans | 1 | 2014 | 11 | 0.490 |
Why?
|
| Occult Blood | 1 | 2015 | 48 | 0.490 |
Why?
|
| Hypothermia, Induced | 5 | 2013 | 93 | 0.480 |
Why?
|
| Periodontal Diseases | 1 | 2015 | 54 | 0.480 |
Why?
|
| Immunity, Innate | 2 | 2020 | 156 | 0.480 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 53 | 0.480 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2018 | 69 | 0.480 |
Why?
|
| Research Design | 1 | 2018 | 729 | 0.470 |
Why?
|
| Prospective Studies | 12 | 2023 | 3705 | 0.460 |
Why?
|
| Hypoxia-Ischemia, Brain | 5 | 2017 | 56 | 0.460 |
Why?
|
| Adipokines | 1 | 2014 | 20 | 0.460 |
Why?
|
| Endocrine System | 1 | 2013 | 11 | 0.460 |
Why?
|
| Autocrine Communication | 1 | 2013 | 37 | 0.450 |
Why?
|
| Calcium | 7 | 2022 | 929 | 0.440 |
Why?
|
| Fetus | 4 | 2022 | 157 | 0.440 |
Why?
|
| Attitude | 3 | 2018 | 121 | 0.440 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 43 | 0.430 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 81 | 0.430 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2018 | 931 | 0.420 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2020 | 1745 | 0.420 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 2022 | 15 | 0.400 |
Why?
|
| Exercise | 1 | 2017 | 658 | 0.390 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1293 | 0.390 |
Why?
|
| Bone Density Conservation Agents | 3 | 2008 | 43 | 0.380 |
Why?
|
| Birth Weight | 6 | 2020 | 186 | 0.380 |
Why?
|
| Leukocytes | 3 | 2022 | 99 | 0.370 |
Why?
|
| Absorptiometry, Photon | 4 | 2018 | 83 | 0.360 |
Why?
|
| South Carolina | 6 | 2018 | 2752 | 0.350 |
Why?
|
| Observational Studies as Topic | 2 | 2020 | 39 | 0.330 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 41 | 0.330 |
Why?
|
| Adolescent | 11 | 2023 | 8912 | 0.330 |
Why?
|
| Calcifediol | 2 | 2023 | 70 | 0.330 |
Why?
|
| Methylmercury Compounds | 2 | 2019 | 19 | 0.320 |
Why?
|
| Mercury | 2 | 2019 | 34 | 0.320 |
Why?
|
| Cohort Studies | 8 | 2018 | 2358 | 0.310 |
Why?
|
| Amniotic Fluid | 1 | 2008 | 30 | 0.310 |
Why?
|
| Neonatology | 4 | 2002 | 29 | 0.300 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 63 | 0.300 |
Why?
|
| Personality | 2 | 2006 | 66 | 0.300 |
Why?
|
| Abscess | 1 | 2007 | 37 | 0.290 |
Why?
|
| Mood Disorders | 1 | 2008 | 132 | 0.290 |
Why?
|
| Breast Diseases | 1 | 2007 | 40 | 0.290 |
Why?
|
| Macrophages | 4 | 2015 | 647 | 0.290 |
Why?
|
| Risk Factors | 10 | 2019 | 5731 | 0.280 |
Why?
|
| Permeability | 3 | 2015 | 131 | 0.280 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1054 | 0.280 |
Why?
|
| Intensive Care Units, Neonatal | 6 | 2022 | 113 | 0.270 |
Why?
|
| Environmental Exposure | 2 | 2019 | 269 | 0.270 |
Why?
|
| Animals | 14 | 2019 | 20881 | 0.270 |
Why?
|
| Child, Preschool | 5 | 2020 | 3187 | 0.260 |
Why?
|
| Adipose Tissue | 3 | 2018 | 221 | 0.260 |
Why?
|
| Transportation of Patients | 2 | 2002 | 46 | 0.250 |
Why?
|
| Physicians, Family | 2 | 2002 | 83 | 0.250 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2005 | 60 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2017 | 1664 | 0.240 |
Why?
|
| Shock, Septic | 1 | 2005 | 101 | 0.240 |
Why?
|
| Overweight | 3 | 2021 | 186 | 0.240 |
Why?
|
| Caregivers | 2 | 2020 | 365 | 0.230 |
Why?
|
| Developmental Disabilities | 2 | 2002 | 119 | 0.230 |
Why?
|
| Inflammation | 4 | 2020 | 1030 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 529 | 0.220 |
Why?
|
| Interleukin-12 | 2 | 2022 | 75 | 0.220 |
Why?
|
| Calcitriol | 2 | 2014 | 106 | 0.220 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2005 | 138 | 0.220 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 3259 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 5 | 2016 | 772 | 0.210 |
Why?
|
| Treatment Outcome | 11 | 2017 | 7029 | 0.210 |
Why?
|
| Logistic Models | 5 | 2017 | 1420 | 0.210 |
Why?
|
| Child Nutrition Sciences | 1 | 2002 | 5 | 0.210 |
Why?
|
| Infant Nutrition Disorders | 2 | 2017 | 6 | 0.210 |
Why?
|
| Health Information Systems | 1 | 2022 | 18 | 0.210 |
Why?
|
| Intestine, Small | 2 | 2000 | 89 | 0.210 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 38 | 0.210 |
Why?
|
| Respiratory Sounds | 2 | 2020 | 35 | 0.210 |
Why?
|
| Peripartum Period | 1 | 2022 | 15 | 0.200 |
Why?
|
| Lipids | 1 | 2004 | 298 | 0.200 |
Why?
|
| Food Storage | 1 | 2021 | 7 | 0.200 |
Why?
|
| Caseins | 1 | 2021 | 19 | 0.200 |
Why?
|
| Resuscitation | 1 | 2002 | 77 | 0.200 |
Why?
|
| Fetal Blood | 4 | 2017 | 131 | 0.200 |
Why?
|
| Powders | 1 | 2021 | 32 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2012 | 46 | 0.190 |
Why?
|
| Immune System | 4 | 2015 | 63 | 0.190 |
Why?
|
| Respiration, Artificial | 3 | 2014 | 190 | 0.190 |
Why?
|
| Pilot Projects | 5 | 2015 | 1342 | 0.190 |
Why?
|
| Home Nursing | 1 | 2000 | 8 | 0.190 |
Why?
|
| New York | 2 | 2017 | 223 | 0.190 |
Why?
|
| Feeding Methods | 1 | 2020 | 17 | 0.190 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2800 | 0.180 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 37 | 0.180 |
Why?
|
| Risk | 2 | 2015 | 563 | 0.180 |
Why?
|
| Hot Temperature | 1 | 2001 | 152 | 0.180 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 2019 | 5 | 0.170 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 848 | 0.170 |
Why?
|
| Growth Substances | 1 | 2000 | 77 | 0.170 |
Why?
|
| Pregnancy in Diabetics | 1 | 2020 | 70 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2020 | 114 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 232 | 0.170 |
Why?
|
| International Agencies | 1 | 2019 | 17 | 0.170 |
Why?
|
| Asphyxia Neonatorum | 1 | 1999 | 14 | 0.170 |
Why?
|
| Therapeutic Equivalency | 1 | 2019 | 21 | 0.170 |
Why?
|
| Dosage Forms | 1 | 2019 | 20 | 0.170 |
Why?
|
| Incidence | 4 | 2019 | 1603 | 0.170 |
Why?
|
| Fetal Development | 2 | 2011 | 70 | 0.170 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 85 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 214 | 0.170 |
Why?
|
| Vaginosis, Bacterial | 1 | 2019 | 24 | 0.170 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 1999 | 8 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2015 | 57 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2000 | 163 | 0.160 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 54 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 260 | 0.160 |
Why?
|
| Culture Media | 1 | 1998 | 155 | 0.160 |
Why?
|
| DNA Methylation | 1 | 2020 | 193 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 163 | 0.160 |
Why?
|
| Child Development | 3 | 2014 | 102 | 0.160 |
Why?
|
| Gene Expression | 2 | 2020 | 770 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 384 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 425 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2015 | 652 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2000 | 294 | 0.150 |
Why?
|
| Parturition | 1 | 2017 | 15 | 0.150 |
Why?
|
| Calcium, Dietary | 2 | 2019 | 35 | 0.150 |
Why?
|
| Antibodies | 1 | 1998 | 241 | 0.150 |
Why?
|
| Adiponectin | 1 | 2017 | 52 | 0.150 |
Why?
|
| Stem Cells | 1 | 2019 | 248 | 0.150 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 46 | 0.150 |
Why?
|
| Infant Care | 2 | 2016 | 31 | 0.150 |
Why?
|
| Adiposity | 1 | 2018 | 88 | 0.150 |
Why?
|
| Insurance, Health | 1 | 1999 | 201 | 0.150 |
Why?
|
| Pulmonary Alveoli | 2 | 2016 | 62 | 0.150 |
Why?
|
| Family | 1 | 2019 | 293 | 0.140 |
Why?
|
| Radioimmunoassay | 4 | 2010 | 164 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.140 |
Why?
|
| Cathelicidins | 1 | 2016 | 11 | 0.140 |
Why?
|
| Weight Gain | 1 | 2017 | 135 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2014 | 954 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 700 | 0.140 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 10 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 226 | 0.130 |
Why?
|
| Genome, Human | 1 | 2016 | 62 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 78 | 0.130 |
Why?
|
| Oximetry | 2 | 2006 | 29 | 0.130 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 56 | 0.130 |
Why?
|
| Molecular Weight | 3 | 2004 | 358 | 0.130 |
Why?
|
| Macrophages, Alveolar | 1 | 1995 | 34 | 0.130 |
Why?
|
| Family Practice | 1 | 2018 | 312 | 0.130 |
Why?
|
| Nutritional Status | 3 | 2022 | 112 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2021 | 824 | 0.130 |
Why?
|
| Prevalence | 1 | 2019 | 1619 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2016 | 172 | 0.130 |
Why?
|
| Motivation | 1 | 2019 | 561 | 0.120 |
Why?
|
| Depression | 1 | 2022 | 943 | 0.120 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 2279 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 130 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 567 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1465 | 0.120 |
Why?
|
| Pulmonary Surfactants | 1 | 2014 | 41 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2014 | 34 | 0.120 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 8 | 0.120 |
Why?
|
| Health Promotion | 1 | 2018 | 407 | 0.120 |
Why?
|
| Infant Food | 2 | 2008 | 16 | 0.120 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2013 | 16 | 0.120 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 11 | 0.110 |
Why?
|
| Ventilator Weaning | 2 | 2004 | 27 | 0.110 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 40 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 1994 | 123 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2015 | 737 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 1026 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2015 | 157 | 0.110 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 115 | 0.110 |
Why?
|
| Time Factors | 7 | 2017 | 4655 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2673 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2015 | 275 | 0.110 |
Why?
|
| Marital Status | 2 | 2006 | 65 | 0.110 |
Why?
|
| Iron, Dietary | 1 | 2013 | 6 | 0.110 |
Why?
|
| United States | 6 | 2014 | 7367 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2013 | 51 | 0.110 |
Why?
|
| Chemokines | 1 | 2013 | 119 | 0.110 |
Why?
|
| Micronutrients | 1 | 2013 | 31 | 0.110 |
Why?
|
| Asthma | 1 | 2017 | 345 | 0.110 |
Why?
|
| Community Health Centers | 1 | 2012 | 26 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2014 | 224 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 15 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 1426 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 282 | 0.100 |
Why?
|
| Energy Intake | 1 | 2013 | 123 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 296 | 0.100 |
Why?
|
| Growth Charts | 1 | 2012 | 16 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2014 | 206 | 0.100 |
Why?
|
| Iran | 2 | 2023 | 12 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2008 | 145 | 0.100 |
Why?
|
| Middle Aged | 7 | 2023 | 21147 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2011 | 56 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 450 | 0.090 |
Why?
|
| Receptors, Calcitriol | 3 | 2017 | 49 | 0.090 |
Why?
|
| Cell Division | 3 | 2002 | 541 | 0.090 |
Why?
|
| Hospitalization | 1 | 2016 | 978 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 955 | 0.090 |
Why?
|
| Quality of Life | 1 | 2018 | 1515 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.090 |
Why?
|
| Aging | 1 | 1995 | 911 | 0.080 |
Why?
|
| 24,25-Dihydroxyvitamin D 3 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 629 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 1998 | 1242 | 0.080 |
Why?
|
| Creatinine | 2 | 2006 | 243 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 207 | 0.080 |
Why?
|
| Hospitals, University | 2 | 2018 | 169 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2014 | 1553 | 0.080 |
Why?
|
| Hydroxycholecalciferols | 1 | 2007 | 29 | 0.070 |
Why?
|
| Maternal Age | 2 | 2006 | 70 | 0.070 |
Why?
|
| Linear Models | 2 | 2019 | 521 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 742 | 0.070 |
Why?
|
| Internationality | 1 | 2007 | 74 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2007 | 95 | 0.070 |
Why?
|
| Seasons | 1 | 2007 | 129 | 0.070 |
Why?
|
| Pediatrics | 2 | 2018 | 341 | 0.070 |
Why?
|
| Expert Systems | 1 | 2006 | 9 | 0.070 |
Why?
|
| Muscle Strength | 1 | 2006 | 62 | 0.070 |
Why?
|
| Risk Management | 1 | 2006 | 37 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2006 | 117 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 306 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2006 | 88 | 0.060 |
Why?
|
| Brain Ischemia | 2 | 2002 | 665 | 0.060 |
Why?
|
| Autopsy | 1 | 2005 | 56 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2006 | 183 | 0.060 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2004 | 5 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 546 | 0.060 |
Why?
|
| Critical Illness | 2 | 2022 | 191 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2004 | 22 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2004 | 26 | 0.060 |
Why?
|
| Neoplasms | 1 | 2015 | 1667 | 0.060 |
Why?
|
| Cause of Death | 1 | 2005 | 241 | 0.060 |
Why?
|
| Biological Availability | 1 | 2004 | 79 | 0.060 |
Why?
|
| Reference Values | 1 | 2005 | 579 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 99 | 0.060 |
Why?
|
| Growth Disorders | 1 | 2003 | 21 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.060 |
Why?
|
| Liposomes | 1 | 2004 | 107 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 252 | 0.050 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2003 | 18 | 0.050 |
Why?
|
| Anemia, Neonatal | 1 | 2002 | 6 | 0.050 |
Why?
|
| Kernicterus | 1 | 2002 | 7 | 0.050 |
Why?
|
| Convalescence | 1 | 2002 | 11 | 0.050 |
Why?
|
| Jaundice, Neonatal | 1 | 2002 | 8 | 0.050 |
Why?
|
| Apnea | 1 | 2002 | 16 | 0.050 |
Why?
|
| Body Temperature Regulation | 1 | 2002 | 29 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2002 | 27 | 0.050 |
Why?
|
| Neurology | 1 | 2002 | 43 | 0.050 |
Why?
|
| Milk Banks | 1 | 2001 | 1 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2002 | 136 | 0.050 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2001 | 19 | 0.050 |
Why?
|
| Vital Capacity | 2 | 2006 | 43 | 0.050 |
Why?
|
| Ampicillin | 1 | 2000 | 17 | 0.050 |
Why?
|
| Bacteria | 1 | 2022 | 193 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2000 | 44 | 0.050 |
Why?
|
| Forced Expiratory Volume | 2 | 2006 | 87 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 2002 | 157 | 0.050 |
Why?
|
| Ceftriaxone | 1 | 2000 | 32 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2004 | 448 | 0.050 |
Why?
|
| Immunity | 1 | 2001 | 67 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 58 | 0.050 |
Why?
|
| Gentamicins | 1 | 2000 | 68 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2000 | 72 | 0.040 |
Why?
|
| Intestines | 1 | 2001 | 114 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2000 | 112 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2020 | 251 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 215 | 0.040 |
Why?
|
| Physician's Role | 2 | 2002 | 116 | 0.040 |
Why?
|
| CpG Islands | 1 | 2020 | 51 | 0.040 |
Why?
|
| Puberty | 1 | 2019 | 10 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 263 | 0.040 |
Why?
|
| Health Education | 1 | 2002 | 279 | 0.040 |
Why?
|
| Critical Care | 1 | 2002 | 263 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 95 | 0.040 |
Why?
|
| Rabbits | 2 | 2002 | 509 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 1999 | 16 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 1999 | 29 | 0.040 |
Why?
|
| Sex Factors | 2 | 2014 | 1266 | 0.040 |
Why?
|
| Health Personnel | 1 | 2002 | 286 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2000 | 110 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2000 | 197 | 0.040 |
Why?
|
| Trial of Labor | 1 | 1999 | 5 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1999 | 7 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 86 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 7277 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2550 | 0.040 |
Why?
|
| Time | 1 | 2019 | 57 | 0.040 |
Why?
|
| Anxiety | 1 | 2022 | 422 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 85 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 455 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2000 | 392 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 649 | 0.040 |
Why?
|
| Seafood | 1 | 2018 | 17 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 291 | 0.040 |
Why?
|
| Anthropometry | 1 | 2018 | 64 | 0.040 |
Why?
|
| Mosaicism | 1 | 1998 | 21 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 1998 | 43 | 0.040 |
Why?
|
| Trisomy | 1 | 1998 | 47 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1998 | 54 | 0.040 |
Why?
|
| ROC Curve | 2 | 2012 | 392 | 0.040 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1998 | 27 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 307 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2018 | 50 | 0.040 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 4 | 0.040 |
Why?
|
| Litter Size | 1 | 2017 | 14 | 0.040 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 24 | 0.040 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2017 | 21 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 1998 | 73 | 0.040 |
Why?
|
| Brain | 2 | 2012 | 2176 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 65 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 100 | 0.040 |
Why?
|
| Drug Therapy | 1 | 1997 | 71 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 196 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 64 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 208 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2018 | 204 | 0.030 |
Why?
|
| Medicaid | 1 | 1999 | 302 | 0.030 |
Why?
|
| Digestive System | 1 | 1996 | 35 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 10 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 16 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 159 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2016 | 89 | 0.030 |
Why?
|
| Maternal Health | 1 | 2015 | 8 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 68 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 94 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 1995 | 58 | 0.030 |
Why?
|
| Decidua | 1 | 2015 | 8 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 554 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 295 | 0.030 |
Why?
|
| Isomerism | 1 | 1995 | 63 | 0.030 |
Why?
|
| Cell Count | 1 | 1995 | 248 | 0.030 |
Why?
|
| Cesarean Section | 1 | 1995 | 101 | 0.030 |
Why?
|
| Age Factors | 1 | 2000 | 1864 | 0.030 |
Why?
|
| Uterus | 1 | 2015 | 77 | 0.030 |
Why?
|
| Prognosis | 2 | 2012 | 2093 | 0.030 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Term Birth | 1 | 2014 | 12 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1994 | 5 | 0.030 |
Why?
|
| Anthracenes | 1 | 2014 | 26 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 71 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4848 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 53 | 0.030 |
Why?
|
| Spirometry | 1 | 1994 | 47 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 57 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2013 | 94 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 140 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 114 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2013 | 24 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 201 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 14862 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 167 | 0.030 |
Why?
|
| Placenta Growth Factor | 1 | 2012 | 12 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2012 | 9 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 97 | 0.030 |
Why?
|
| Global Health | 1 | 2013 | 136 | 0.030 |
Why?
|
| Plethysmography | 1 | 2012 | 17 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 710 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 242 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2012 | 122 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 101 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 238 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 186 | 0.020 |
Why?
|
| Decision Making | 2 | 2006 | 410 | 0.020 |
Why?
|
| Internet | 2 | 2006 | 390 | 0.020 |
Why?
|
| Fetal Weight | 1 | 2011 | 33 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2011 | 79 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 705 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 2791 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 330 | 0.020 |
Why?
|
| Gravidity | 1 | 2010 | 11 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 1753 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 43 | 0.020 |
Why?
|
| Mice | 2 | 2013 | 8474 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 38 | 0.020 |
Why?
|
| Programming Languages | 1 | 2006 | 16 | 0.020 |
Why?
|
| Physical Exertion | 1 | 2006 | 75 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2006 | 75 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2006 | 210 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 940 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 258 | 0.020 |
Why?
|
| Hematuria | 1 | 2005 | 24 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2005 | 45 | 0.020 |
Why?
|
| Acidosis | 1 | 2005 | 31 | 0.020 |
Why?
|
| Bradycardia | 1 | 2005 | 45 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 145 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 568 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 122 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1085 | 0.010 |
Why?
|
| Fucose | 1 | 2004 | 25 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 381 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 298 | 0.010 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2002 | 10 | 0.010 |
Why?
|
| Respiratory Mucosa | 1 | 2002 | 52 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 117 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2002 | 136 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 51 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 232 | 0.010 |
Why?
|
| Emergencies | 1 | 2002 | 107 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 187 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 621 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 396 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Cognition | 1 | 2005 | 513 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 1451 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 786 | 0.010 |
Why?
|
| Ionomycin | 1 | 1999 | 24 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 138 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1999 | 304 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1999 | 228 | 0.010 |
Why?
|
| Monocytes | 1 | 1999 | 210 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 1692 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 489 | 0.010 |
Why?
|
| Contraindications | 1 | 1997 | 52 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1997 | 40 | 0.010 |
Why?
|
| Mass Screening | 1 | 2002 | 843 | 0.010 |
Why?
|
| Apgar Score | 1 | 1995 | 22 | 0.010 |
Why?
|
| Ethanol | 1 | 1997 | 893 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 1070 | 0.010 |
Why?
|